Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1143
TNBC
Basal A
Cetuximab
EGFR
ErbB
7810.006
uM
inf
inf
0.8576 0.8576 0.0000 0.0064
0.5591
0.9730
HCC1187
TNBC
Basal A
Cetuximab
EGFR
ErbB
7811.018
uM
inf
inf
0.6946 0.6946 0.0000 0.1308
-0.0060
0.4694
HCC1187
TNBC
Basal A
Cetuximab
EGFR
ErbB
7812.042
uM
inf
inf
0.5614 0.5614 0.0000 0.0267
0.3674
0.9722
HCC1395
TNBC
Basal B
Cetuximab
EGFR
ErbB
9258.026
uM
inf
inf
0.7953 0.7953 0.0000 0.0354
0.3593
0.5632
HCC1395
TNBC
Basal B
Cetuximab
EGFR
ErbB
7813.018
uM
0.82620
0.82952
0.7195 -0.0101 4.9982 0.0073
0.6447
0.8420
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
9146.122
uM
inf
inf
0.9694 0.9694 0.0000 -0.0404
-1.9847
1.3408
184B5
NM
Basal
Cetuximab
EGFR
ErbB
9095.026
uM
0.04089
0.03186
0.1205 0.1008 0.9024 0.1873
0.9743
1.0168
184A1
NM
Basal
Cetuximab
EGFR
ErbB
7787.018
uM
inf
inf
0.4652 0.4652 0.0000 0.3838
-0.0013
0.3791
600MPE
HR+
Luminal
Cetuximab
EGFR
ErbB
9118.006
uM
inf
inf
0.8545 0.8545 0.0000 0.0747
0.3005
1.1089
184A1
NM
Basal
Cetuximab
EGFR
ErbB
9047.026
uM
0.00360
0.01403
-0.2605 -0.4617 0.4805 0.4918
0.8777
0.5972
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7793.018
uM
inf
inf
0.9318 0.9318 0.0000 0.0067
0.3477
1.3186
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7794.018
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
1.6812
BT-20
TNBC
Basal A
Cetuximab
EGFR
ErbB
5903.102
uM
inf
0.01035
0.7898 0.7837 0.8245 0.0669
0.9137
1.2557
BT-474
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7798.018
uM
inf
inf
1.0028 1.0028 0.0000 -0.0260
-0.7402
1.4461
BT-474
HER2amp
Luminal
Cetuximab
EGFR
ErbB
9158.123
uM
inf
inf
0.7610 0.7610 0.0000 0.0813
0.5069
0.8769
BT-483
HR+
Luminal
Cetuximab
EGFR
ErbB
7801.018
uM
inf
inf
0.7533 0.7533 0.0000 0.1055
0.0672
0.5913
BT-483
HR+
Luminal
Cetuximab
EGFR
ErbB
9186.026
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.5108
BT-549
TNBC
Basal B
Cetuximab
EGFR
ErbB
7804.042
uM
inf
1.1360
0.9560 0.7915 2.6263 -0.0076
0.5868
2.4955
BT-549
TNBC
Basal B
Cetuximab
EGFR
ErbB
10261.026
uM
inf
inf
0.9943 0.9943 0.0000 -0.0202
-1.1867
2.4866
BT-549
TNBC
Basal B
Cetuximab
EGFR
ErbB
9024.018
uM
inf
0.02553
0.8627 0.8547 0.7831 0.0371
0.8155
2.8306
BT-549
TNBC
Basal B
Cetuximab
EGFR
ErbB
7803.042
uM
1.64710
3.27740
0.7927 -0.6886 1.2586 0.0007
0.8536
2.8270
HBL-100
Unknown
Unknown
Cetuximab
EGFR
ErbB
7807.042
uM
inf
inf
1.0098 1.0098 0.0000 -0.0392
-7.7987
2.0250
HBL-100
Unknown
Unknown
Cetuximab
EGFR
ErbB
7808.052
uM
inf
inf
0.9944 0.9944 0.0000 -0.0231
-0.8225
2.4842
HCC1937
TNBC
Basal A
Cetuximab
EGFR
ErbB
7834.018
uM
inf
inf
0.8939 0.8939 0.0000 0.0410
0.4149
1.8951
HCC1937
TNBC
Basal A
Cetuximab
EGFR
ErbB
7833.042
uM
inf
inf
0.8856 0.8856 0.0000 0.0972
0.0274
1.0332